Fermenta Biotech gets nod to raise Rs 150 crore

10 Dec 2025 Evaluate

Fermenta Biotech has received approval for raising of funds either by way of issuance of equity shares and/or other securities including securities convertible into equity shares, warrants or fully convertible debentures, partly convertible debentures, non-convertible debentures along with warrants, or convertible preference shares (collectively ‘Securities’), for an aggregate amount not exceeding Rs 150 crore, by way of public issue, rights issue, preferential allotment, private placement, including Qualified Institutions Placement(s) (QIP) in one or more tranches or any other mode or combination thereof as may be permitted under applicable laws, such regulatory/statutory approvals as may be required, and subject to approval of shareholders of the Company, which will be sought separately at the appropriate time. The Board of Directors of the Company, at its meeting held on December 10, 2025, has, inter alia, considered and approved the same. 

Fermenta Biotech possesses a growing portfolio of nutrition including customized Premixes, Fortified Rice Kernel (FRK) and other nutritional ingredients. Apart from its nutrition portfolio, the company is one of the world’s leading manufacturers of Vitamin D3.


Fermenta Biotech Share Price

350.70 -0.45 (-0.13%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×